Web Results

Diclofenamide

en.wikipedia.org/wiki/Diclofenamide

Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class.

Dichlorphenamide medical facts from Drugs.com

www.drugs.com/mtm/dichlorphenamide.html

Physician reviewed dichlorphenamide patient information - includes dichlorphenamide description, dosage and directions.

dichlorphenamide | C6H6Cl2N2O4S2 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/dichlorphenamide

dichlorphenamide | C6H6Cl2N2O4S2 | CID 3038 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological ...

Keveyis (dichlorphenamide) dosing, indications, interactions ...

reference.medscape.com/drug/keveyis-dichlorphenamide-1000046

Medscape - Periodic paralysis indication dosing for Keveyis (dichlorphenamide), frequency-based adverse effects, comprehensive interactions, ...

Dichlorphenamide (Oral Route) Description and Brand Names ...

www.mayoclinic.org/drugs-supplements/dichlorphenamide-oral-route/description/drg-20151242

Dec 1, 2015 ... Dichlorphenamide is used to treat inherited muscle disorders, such as primary hyperkalemic periodic paralysis, primary hypokalemic periodic ...

dichlorphenamide oral : Uses, Side Effects, Interactions, Pictures ...

www.webmd.com/drugs/2/drug-8770/dichlorphenamide-oral/details

Find patient medical information for dichlorphenamide oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ...

DrugBank: Diclofenamide

www.drugbank.ca/drugs/DB01144

Jun 13, 2005 ... 4,5-dichloro-m-benzenedisulfonamide. 4,5-DICHLOROBENZENE-1,3- disulfonamide. Dichlofenamide. Dichlorophenamide. Dichlorphenamide.

Keveyis - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2015/011366s030lbl.pdf

KEVEYISTM (dichlorphenamide) tablets, for oral use. Initial U.S. Approval: ... Hypersensitivity to dichlorphenamide or other sulfonamides (4). • Concomitant use ...

Dichlorphenamide Being Tested in Periodic Paralysis | Quest ...

quest.mda.org/news/dichlorphenamide-being-tested-periodic-paralysis

Oct 14, 2011 ... A phase 3 trial of the drug dichlorphenamide in hyperkalemic and hypokalemic periodic paralysis is open at several U.S. and European centers.

Dichlorphenamide (Keveyis) for Periodic Paralysis | The Medical ...

secure.medicalletter.org/TML-article-1492d

Apr 11, 2016 ... Dichlorphenamide (Keveyis – Taro), an oral carbonic anhydrase inhibitor, has been approved by the FDA for treatment of primary hypokalemic ...

Answer
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.
More Info

Keveyis (Dichlorphenamide Tablets) Drug Information: Description ...

www.rxlist.com

Aug 24, 2015 ... KEVEYIS™ (dichlorphenamide) tablets is an oral carbonic anhydrase inhibitor. Dichlorphenamide, a dichlorinated benzenedisulfonamide, ...

FDA Approves Taro's Keveyis™ (dichlorphenamide) 50 mg Tablets ...

www.businesswire.com

Aug 10, 2015 ... FDA Approves Taro's Keveyis™ (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis.

Dichlorphenamide Shows Clear Benefit in Periodic Paralysis

www.medscape.com

Apr 22, 2016 ... Dichlorphenamide reduces the rate and severity of muscle weakness attacks and improves quality of life in patients with hypokalemic and ...